Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators
Nick Wilson, Vanessa Selak, Tony Blakely, Josh Knight, Nhung Nghiem, William Leung, Philip Clarke, Rod Jackson
NEW ZEALAND MEDICAL JOURNAL | NEW ZEALAND MEDICAL ASSOC | Published : 2016
Awarded by Health Research Council of New Zealand (HRC)
The BODE3 Programme is funded by the Health Research Council of New Zealand (HRC), Grant 10/248. Vanessa Selak is also funded by the HRC for the development of an aspirin harm benefit calculator (Grant 15/165).